查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1407382

数位乳房 X 光检查市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、最终用户区域和竞争细分

Digital Mammography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By End-User Region and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球数位乳房 X 光摄影市场价值为 11.2 亿美元，预计在预测期内将强劲增长，到 2028 年复合CAGR为9.39%。全球数位乳房X 光摄影市场近年来经历了显着的成长和转型，彻底改变了格局乳癌诊断。数位乳房X光检查是一种最先进的影像技术，它取代了传统的基于胶片的乳房X光检查，提供卓越的影像品质、更高的诊断准确性和简化的工作流程。该市场的扩张主要是由于全球乳癌盛行率的上升，以及人们意识的提高和早期检测措施的推动。数位乳房X光检查有助于检测乳房异常，包括肿瘤和钙化，具有更高的敏感性和特异性，从而改善结果并降低死亡率。

数位乳房X光摄影技术的进步在市场发展中发挥了关键作用。全视野数位乳房X光摄影（FFDM）和数位乳房断层合成（DBT）等创新技术日益受到重视，它们提供的三维成像功能可以提供更全面、更详细的乳房组织视图。事实证明，这对于克服传统二维乳房X光摄影的局限性特别有益，特别是在涉及緻密乳房组织的情况下。此外，人工智慧（AI）和机器学习演算法的整合透过协助放射科医生解读乳房X光影像、减少误报并提高效率，进一步提高了诊断准确性。

全球数位乳房X光摄影市场的特点是竞争格局，主要参与者投资于研发活动，以引入尖端技术并获得竞争优势。从地理上看，由于数位乳房X光检查系统的早期采用、强大的医疗基础设施和乳癌的高盛行率，北美在市场上占据主导地位。然而，由于医疗保健意识的提高、医疗保健基础设施的改善和可支配收入的增加，亚太和拉丁美洲的新兴经济体对数位乳房X光检查的需求不断增长。

市场概况
预测期 2024-2028
2022 年市场规模 11.2亿美元
2028 年市场规模 19亿美元
2023-2028 年CAGR 9.39%
成长最快的细分市场 亚太地区
最大的市场 北美洲

主要市场驱动因素

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：全球数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 副产品（2D 全视野数位乳房 X 光断层合成、3D 全视野数位乳房 X 光断层合成）
    • 按最终使用者（医院、门诊手术中心、其他最终使用者）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图
    • 按产品分类
    • 按最终用户
    • 按地区

第 5 章：亚太地区数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国数位乳房X光摄影
    • 印度数位乳房X光摄影
    • 澳洲数位乳房X光摄影
    • 日本数位乳房X光摄影
    • 韩国数位乳房X光摄影

第 6 章：欧洲数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 7 章：北美数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章：南美洲数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 9 章：中东和非洲数位乳房 X 光摄影市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非数位乳房X光摄影
    • 沙乌地阿拉伯数位乳房X光摄影
    • 阿联酋数位乳房X光摄影
    • 埃及数位乳房X光摄影

第 10 章：市场动态

  • 司机
  • 挑战

第 11 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 12 章：全球数位乳房 X 光摄影市场：SWOT 分析

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • 豪洛捷公司
    • Company Snapshot
    • Products & Services
    • Current Capacity Analysis
    • Financials (In case of listed)
    • Recent Developments
    • SWOT Analysis
  • 通用电气医疗集团
  • 皇家飞利浦公司
  • 西门子医疗股份有限公司
  • 富士软片株式会社
  • 普兰梅德公司
  • 东芝医疗系统
  • 金属电子公司

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 20249

Global Digital Mammography Market has valued at USD 1.12 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.39% through 2028. The Global Digital Mammography Market has experienced significant growth and transformation in recent years, revolutionizing the landscape of breast cancer diagnostics. Digital mammography, a state-of-the-art imaging technology, has replaced traditional film-based mammography, offering superior image quality, enhanced diagnostic accuracy, and streamlined workflow. The market's expansion is primarily driven by the rising prevalence of breast cancer worldwide, coupled with increasing awareness and early detection initiatives. Digital mammography facilitates the detection of breast abnormalities, including tumors and calcifications, with greater sensitivity and specificity, leading to improved outcomes and reduced mortality rates.

Technological advancements in digital mammography have played a pivotal role in market evolution. Innovations such as full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) have gained prominence, providing three-dimensional imaging capabilities that offer a more comprehensive and detailed view of breast tissue. This has proven particularly beneficial in overcoming the limitations of conventional two-dimensional mammography, especially in cases involving dense breast tissue. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms has further augmented the diagnostic accuracy by assisting radiologists in the interpretation of mammographic images, reducing false positives and enhancing efficiency.

The global digital mammography market is characterized by a competitive landscape with key players investing in research and development activities to introduce cutting-edge technologies and gain a competitive edge. Geographically, North America has dominated the market, driven by the early adoption of digital mammography systems, robust healthcare infrastructure, and a high prevalence of breast cancer. However, emerging economies in Asia-Pacific and Latin America are witnessing a growing demand for digital mammography, attributed to increasing healthcare awareness, improving healthcare infrastructure, and rising disposable incomes.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.12 Billion
Market Size 2028USD 1.90 Billion
CAGR 2023-20289.39%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Breast Cancer

The increasing prevalence of breast cancer has become a driving force behind the growth of the global digital mammography market. Breast cancer remains one of the most common cancers globally, affecting millions of women each year. As awareness campaigns and early detection initiatives gain momentum, the demand for advanced diagnostic technologies such as digital mammography is on the rise. Digital mammography offers several advantages over traditional film-based mammography, including improved image quality, faster image acquisition, and the ability to manipulate and store digital images efficiently. These advantages are crucial in the early detection of breast cancer, enabling healthcare professionals to identify abnormalities with greater precision.

The global digital mammography market is witnessing substantial expansion as healthcare providers increasingly recognize the importance of early detection in improving treatment outcomes and reducing mortality rates associated with breast cancer. Governments and healthcare organizations worldwide are investing in screening programs and infrastructure to facilitate widespread access to digital mammography services. The integration of artificial intelligence (AI) and machine learning algorithms in digital mammography systems further enhances diagnostic accuracy, aiding radiologists in the interpretation of complex images and reducing the likelihood of false positives or negatives.

Moreover, the rising prevalence of breast cancer is prompting technological advancements within the digital mammography market. Ongoing research and development efforts are focused on innovations such as 3D digital breast tomosynthesis, which provides a three-dimensional view of the breast, offering additional information for a more comprehensive assessment of breast abnormalities. These advancements contribute to the market's growth by addressing the limitations of traditional mammography and improving the overall diagnostic capabilities. As the global healthcare landscape continues to evolve, the digital mammography market is positioned to play a pivotal role in the fight against breast cancer. The increasing prevalence of breast cancer serves as a catalyst for technological innovation, creating a positive feedback loop where advancements in digital mammography contribute to more effective screening, early detection, and improved patient outcomes.

Technological Advancements in Digital Mammography

Technological advancements in digital mammography are serving as a driving force behind the robust growth of the Global Digital Mammography Market. Over the years, the field has witnessed transformative innovations, such as Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT), which have revolutionized breast imaging. FFDM provides high-resolution digital images, offering enhanced clarity and detail compared to traditional film-based mammography. This advancement not only facilitates more accurate detection of abnormalities but also streamlines the diagnostic process with faster image processing times. Digital Breast Tomosynthesis, or 3D mammography, has emerged as a breakthrough technology, addressing the limitations of 2D imaging, particularly in cases of dense breast tissue. By capturing multiple images from various angles, DBT provides three-dimensional views, enabling healthcare professionals to navigate through breast tissue layers, improving diagnostic accuracy.

Moreover, the integration of Artificial Intelligence (AI) and Machine Learning (ML) has further propelled the technological evolution of digital mammography. AI algorithms assist radiologists in analyzing mammographic images, offering a second layer of intelligent interpretation. These algorithms can identify subtle patterns and potential abnormalities, aiding in the early detection of breast cancer. The continuous refinement of these AI tools contributes to reducing false positives and negatives, ultimately enhancing diagnostic precision. The amalgamation of AI and digital mammography not only improves accuracy but also streamlines workflow, making the diagnostic process more efficient.

The ongoing research and development initiatives in the field of digital mammography continue to push the boundaries of technology, with a focus on improving image quality, reducing radiation exposure, and enhancing the overall patient experience. The incorporation of advanced features, such as computer-aided detection (CAD) systems, adds another layer of sophistication to digital mammography, allowing for a more comprehensive and nuanced analysis of breast images.

Growing Awareness and Early Detection Initiatives

The Global Digital Mammography Market is experiencing a significant upswing, propelled by the growing awareness of breast health and the implementation of early detection initiatives. Increasingly, governments, non-profit organizations, and healthcare institutions are championing breast cancer awareness campaigns, underscoring the importance of regular screenings and early diagnosis. This heightened awareness has resulted in a greater emphasis on advanced diagnostic technologies, with digital mammography emerging as a key player in this landscape. As women become more proactive about their health and well-being, the demand for efficient and accurate breast cancer screening methods has risen. Digital mammography, with its superior imaging capabilities and ability to detect abnormalities at early stages, aligns seamlessly with the objectives of these awareness campaigns.

Early detection initiatives, often accompanied by advocacy programs, encourage women to undergo routine screenings for breast cancer. The accessibility and efficiency of digital mammography make it a valuable tool in reaching these objectives. The technology's ability to provide high-resolution images, facilitate faster processing times, and offer three-dimensional views through techniques like Digital Breast Tomosynthesis (DBT) has positioned it as a preferred choice for early detection efforts. Moreover, the integration of Artificial Intelligence (AI) in digital mammography enhances diagnostic accuracy, reducing the likelihood of false positives and negatives.

The global shift towards proactive healthcare, coupled with the empowerment of individuals through awareness campaigns, has translated into a growing market for digital mammography. Healthcare providers and institutions are increasingly investing in these advanced technologies to meet the rising demand for early detection services. The synergy between awareness initiatives and the capabilities of digital mammography contributes not only to the diagnosis of breast cancer but also to a broader culture of preventative healthcare.

Key Market Challenges

High Initial Costs and Economic Constraints

The Global Digital Mammography Market, while experiencing significant growth, grapples with a formidable challenge - the high initial costs and economic constraints associated with adopting advanced digital mammography technologies. The deployment of state-of-the-art digital mammography systems requires a substantial upfront investment, posing a barrier to accessibility, particularly in resource-constrained healthcare settings.

The technology involves cutting-edge imaging systems, often accompanied by advanced software for image processing and analysis. While these innovations contribute to superior diagnostic accuracy and improved patient outcomes, they come at a considerable price. Healthcare institutions, especially those in developing regions, often face budgetary constraints that make it challenging to allocate funds for such high-cost investments.

Addressing this challenge requires a multifaceted approach. Collaboration between governments, healthcare institutions, and technology providers is crucial in developing innovative financial models and funding mechanisms. Public-private partnerships can play a pivotal role in facilitating the acquisition of digital mammography systems, ensuring that the financial burden is shared and that the benefits of advanced breast cancer detection technologies are extended to a broader spectrum of the population.

Furthermore, the industry must explore avenues for cost reduction without compromising the quality of care. Research and development efforts focused on developing more cost-effective digital mammography solutions can pave the way for affordable alternatives. This could involve innovations in manufacturing processes, materials, or even the integration of open-source technologies to reduce licensing and operational costs.

Radiation Exposure Concerns

Radiation exposure concerns stand as a significant obstacle in the path of the Global Digital Mammography Market. While digital mammography has proven instrumental in early breast cancer detection, anxieties regarding ionizing radiation persist among both healthcare professionals and patients, posing challenges to widespread acceptance and adoption.

Traditional mammography involves the use of ionizing radiation to create detailed images of breast tissue. While the radiation dose is generally considered low and safe, the cumulative effects of repeated exposure during routine screenings have prompted concerns. Patients, already grappling with the emotional burden of potential cancer diagnoses, are increasingly mindful of the long-term health implications associated with radiation exposure. This heightened awareness has led to a demand for alternative imaging technologies that offer diagnostic precision without compromising safety.

In response to these concerns, the industry has been actively exploring ways to minimize radiation exposure without sacrificing the diagnostic efficacy of digital mammography. Ongoing research and development efforts focus on developing low-dose imaging technologies, aiming to strike a delicate balance between obtaining high-quality diagnostic images and ensuring patient safety. Innovations in detector technology, image processing algorithms, and dose modulation techniques are continuously evolving to address radiation-related apprehensions.

Moreover, advocacy for adherence to dose optimization principles and guidelines has gained prominence within the medical community. Healthcare providers are encouraged to employ techniques that tailor radiation doses to individual patient characteristics, ensuring that the benefits of early breast cancer detection outweigh potential risks. Standardization of protocols and the establishment of guidelines for radiation dose management contribute to a more systematic and controlled approach to addressing radiation exposure concerns.

Key Market Trends

Rise of 3D Mammography (Digital Breast Tomosynthesis)

The rise of 3D mammography, also known as digital breast tomosynthesis (DBT), has emerged as a transformative force propelling the global digital mammography market to new heights. Digital breast tomosynthesis represents a significant advancement over traditional 2D mammography by providing a three-dimensional view of the breast tissue. This revolutionary technology allows radiologists to examine the breast in multiple thin slices, offering a more detailed and comprehensive assessment of abnormalities. As breast cancer detection and diagnosis become increasingly sophisticated, the demand for 3D mammography has surged, driven by its ability to improve the accuracy of breast cancer screenings.

One of the key factors contributing to the growth of the global digital mammography market is the enhanced diagnostic capabilities offered by 3D mammography. This technology reduces the limitations associated with overlapping breast tissue in traditional 2D mammography, leading to a reduction in false positives and false negatives. The improved accuracy translates to better-informed clinical decisions, ensuring that potential abnormalities are identified more precisely. As a result, 3D mammography is becoming the standard of care in breast cancer screening, further driving its adoption and contributing to the overall expansion of the digital mammography market.

Moreover, the rise of 3D mammography aligns with a broader trend of technological integration within the healthcare sector. The incorporation of artificial intelligence (AI) algorithms into 3D mammography systems enhances the interpretation of images, aiding radiologists in detecting subtle abnormalities and streamlining the diagnostic process. The synergy between 3D mammography and AI not only improves the efficiency of breast cancer screenings but also augments the capabilities of healthcare professionals in identifying and addressing potential issues at an earlier stage.

Integration of Artificial Intelligence (AI) and Machine Learning (ML)

The integration of Artificial Intelligence (AI) and Machine Learning (ML) is playing a pivotal role in boosting the global digital mammography market, revolutionizing the landscape of breast cancer detection and diagnosis. AI and ML algorithms have become indispensable tools in enhancing the capabilities of digital mammography systems, offering a sophisticated layer of intelligence to the interpretation of mammographic images. One of the key advantages is the ability of these technologies to analyze vast datasets quickly and accurately, assisting healthcare professionals in identifying subtle patterns and anomalies that may be indicative of breast cancer.

The utilization of AI and ML in digital mammography significantly contributes to improving diagnostic accuracy and efficiency. These technologies can assist radiologists in distinguishing between benign and malignant lesions, reducing the incidence of false positives and false negatives. By leveraging the power of machine learning, digital mammography systems can continuously learn and adapt, refining their diagnostic capabilities over time. This adaptive nature ensures that the technology remains at the forefront of breast cancer detection, constantly evolving to meet the demands of an ever-changing healthcare landscape.

Furthermore, AI and ML algorithms bring automation to the interpretation process, enabling faster and more standardized assessments of mammographic images. This not only enhances the speed of diagnosis but also promotes consistency across different healthcare settings. The ability of these technologies to handle complex data sets and identify subtle patterns that may escape the human eye empowers healthcare professionals with a valuable tool for early detection and intervention. The global digital mammography market is witnessing a surge in demand for AI and ML-integrated solutions as healthcare providers recognize the transformative impact on patient outcomes. Governments and institutions are increasingly investing in the implementation of these technologies to improve breast cancer screening programs and reduce the burden on healthcare systems.

Segmental Insights

Product Insights

Based on the Product, 3D Full Field Digital Mammography Tomosynthesis emerged as the dominant segment in the global market for Global Digital Mammography in 2022. The primary reason for the high demand for 3D DBT lies in its ability to address some limitations associated with traditional 2D FFDM. While 2D mammography provides valuable information for breast cancer screening, it may encounter challenges in cases involving dense breast tissue. Dense breasts can sometimes obscure abnormalities, leading to false negatives or inconclusive results.

End-User Insights

Based on the End-User, hospitals emerged as the dominant segment in the global market for Global Digital Mammography Market in 2022. Hospitals are key institutions that provide a wide range of healthcare services, including diagnostic imaging. Digital mammography is a critical tool for breast cancer screening and diagnosis, making it an integral part of the services offered by hospitals.Many hospitals have specialized breast health centers within their facilities. These centers focus specifically on breast imaging, screening, and diagnosis. Given the importance of mammography in breast cancer detection, hospitals with dedicated breast health centers are significant contributors to the demand for digital mammography systems.

Regional Insights

North America emerged as the dominant player in the Global Digital Mammography Market in 2022, holding the largest market share. North America, particularly the United States, is known for its early adoption of advanced healthcare technologies. The region often serves as an early adopter for cutting-edge medical imaging equipment, including digital mammography systems. The well-developed healthcare infrastructure in North America, including a network of hospitals, clinics, and imaging centers, supports the widespread adoption of digital mammography. Accessibility to advanced healthcare services contributes to the market's growth in the region.

Key Market Players

Hologic Inc

GE Healthcare

Koninklijke Philips NV

Siemens Healthcare GmBH

Fujifilm Corporation

Planmed Oy

Toshiba Medical Systems

Metaltronica S.p.A

Report Scope:

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Digital Mammography Market, By Product:

  • 2D Full Field Digital Mammography Tomosynthesis
  • 3D Full Field Digital Mammography Tomosynthesis

Global Digital Mammography Market, By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

Global Digital Mammography Market, By Application:

  • Clinical
  • System

Global Digital Mammography Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

  • Global Digital Mammography Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Digital Mammography Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis)
    • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
    • 4.2.3. By Region
    • 4.2.4. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By End-User
    • 4.3.3. By Region

5. Asia Pacific Digital Mammography Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By End-User
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Digital Mammography Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By End-User
    • 5.3.2. India Digital Mammography Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By End-User
    • 5.3.3. Australia Digital Mammography Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By End-User
    • 5.3.4. Japan Digital Mammography Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By End-User
    • 5.3.5. South Korea Digital Mammography Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By End-User

6. Europe Digital Mammography Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Digital Mammography Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-User
    • 6.3.2. Germany Digital Mammography Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-User
    • 6.3.3. Spain Digital Mammography Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-User
    • 6.3.4. Italy Digital Mammography Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By End-User
    • 6.3.5. United Kingdom Digital Mammography Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By End-User

7. North America Digital Mammography Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Digital Mammography Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-User
    • 7.3.2. Mexico Digital Mammography Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-User
    • 7.3.3. Canada Digital Mammography Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-User

8. South America Digital Mammography Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Digital Mammography Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-User
    • 8.3.2. Argentina Digital Mammography Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-User
    • 8.3.3. Colombia Digital Mammography Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-User

9. Middle East and Africa Digital Mammography Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Digital Mammography Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-User
    • 9.3.2. Saudi Arabia Digital Mammography Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-User
    • 9.3.3. UAE Digital Mammography Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-User
    • 9.3.4. Egypt Digital Mammography Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Digital Mammography Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Hologic Inc.
    • 14.1.1. Company Snapshot
    • 14.1.2. Products & Services
    • 14.1.3. Current Capacity Analysis
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. GE Healthcare
  • 14.3. Koninklijke Philips NV
  • 14.4. Siemens Healthcare GmBH
  • 14.5. Fujifilm Corporation
  • 14.6. Planmed Oy
  • 14.7. Toshiba Medical Systems
  • 14.8. Metaltronica S.p.A

15. Strategic Recommendations

16. About Us & Disclaimer